UPRICHARD DAVID C 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed May 31, 2019
Insider Transaction Report
Form 4
UPRICHARD DAVID C
Director
Transactions
- Award
Stock Option (right to buy)
2019-05-29+18,750→ 18,750 totalExercise: $0.64From: 2020-05-29Exp: 2029-05-29→ Common Stock (18,750 underlying)
Footnotes (1)
- [F1]These options were granted to Dr. U'Prichard for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.